CS logo
small CS logo
Istituto Regina Elena, Divisione di Oncologia Medica

Roma, Italy
Policlinico in Italia

About Istituto Regina Elena, Divisione di Oncologia Medica


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Istituto Regina Elena, Divisione di Oncologia Medica


During the past decade, Istituto Regina Elena, Divisione di Oncologia Medica conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Regina Elena, Divisione di Oncologia Medica" #1 collaborator was "Princess Margaret Hospital, Canada" with 1 trials as a collaborator, "San Giuseppe Moscati Hospital" with 1 trials as a collaborator, "University of Alberta" with 1 trials as a collaborator and "University of Campania "Luigi Vanvitelli"" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Istituto Regina Elena, Divisione di Oncologia Medica


According to Clinical.Site data, the most researched conditions in "Istituto Regina Elena, Divisione di Oncologia Medica" are "Advanced Non-Small Cell Lung Cancer" (1 trials), "Advanced Non-small Cell Lung Cancer" (1 trials), "Ovarian Cancer" (1 trials) and "Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Istituto Regina Elena, Divisione di Oncologia Medica" in a lesser frequency.

Clinical Trials Intervention Types at Istituto Regina Elena, Divisione di Oncologia Medica


Most popular intervention types in "Istituto Regina Elena, Divisione di Oncologia Medica" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "cisplatin" (3 trials), "gemcitabine" (3 trials), "carboplatin" (2 trials), "erlotinib" (1 trials) and "etoposide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Istituto Regina Elena, Divisione di Oncologia Medica


The vast majority of trials in "Istituto Regina Elena, Divisione di Oncologia Medica" are 3 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Istituto Regina Elena, Divisione di Oncologia Medica


Currently, there are NaN active trials in "Istituto Regina Elena, Divisione di Oncologia Medica". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Istituto Regina Elena, Divisione di Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Regina Elena, Divisione di Oncologia Medica, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".